Research background: Retatrutide is a unimolecular peptide engineered to act as an agonist at three distinct receptors — GLP-1, GIP, and glucagon. This triple-receptor activity has attracted substantial attention in metabolic and endocrine research literature, as models combining incretin and glucagon receptor pathways have shown differentiated effects compared to single- or dual-agonist compounds in preclinical studies.
Literature: Coskun et al., Cell Metabolism (2022) — receptor pharmacology and preclinical model data.
Reconstitution guidance
This product is supplied as a lyophilised (freeze-dried) powder and requires reconstitution with bacteriostatic water prior to use in a research setting. Standard laboratory practice is to add the diluent slowly down the inside wall of the vial and gently swirl — never shake — to avoid denaturing the peptide structure. Reconstituted solution should be stored at 2-8°C and used within the timeframe indicated by standard peptide stability literature.
Storage
Store lyophilised powder at -20°C upon receipt. Once reconstituted, keep refrigerated and shielded from light. All VeridianLabs cold-chain shipments arrive with insulated packaging to preserve compound integrity in transit.
Frequently asked questions
What purity does this batch meet?
Independent HPLC testing confirmed 99.68% purity, exceeding our 98% minimum acceptance threshold.
Is a Certificate of Analysis available?
Yes. A COA is available on request, issued by Freedom Diagnostics (accession #2605180467, lot MR5E512).
Is this product intended for human or veterinary use?
No. This product is sold strictly for in vitro laboratory research purposes (RUO) and must not be administered to humans or animals.
Strictly for laboratory research use only (RUO). Not for human or veterinary use, not for diagnostic or therapeutic purposes, not a consumer product.
Reviews
There are no reviews yet.